MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cgh.2025.07.011

Медицинская библиотека · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025

Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD.

Zhou Xiao-Dong, Li Yu-Ting, Kim Seung Up, Yip Terry Cheuk-Fung, Petta Salvatore, Nakajima Atsushi, Tsochatzis Emmanuel, Shi Junping, Chan Wah-Kheong, Boursier Jérôme, Bugianesi Elisabetta, Yilmaz Yusuf, Hagström Hannes, Romero-Gomez Manuel, Alswat Khalid, Calleja José Luis, Takahashi Hirokazu, de Lédinghen Victor, Shalimar, Castéra Laurent, Sanyal Arun J, Goh George Boon-Bee, Newsome Philip N, Fan Jian-Gao, Lai Michelle, Aggarwal Sandeep, Kechagias Stergios, Hiasa Yoichi, Zhang Zhongtao, George Jacob, El-Kassas Mohamed, Chen Jinjun, You Hong, Abu Dayyeh Barham K, Sheng Huiping, Adams Leon A, Wang Jing, He Fangping, Liang Huiqing, Yang Yong-Feng, Chi Xiaoling, Zhong Bihui, Bi Yan, Mi Yuqiang, Zhu Yongfen, Bai Rixing, Zhang Jing, Wang Bingyuan, Song Jinghai, Deng Hong, Xie Qing, Bai Lang, Xin Yongning, Xie Wen, Li Jie, Fournier-Poizat Céline, Wu Chutian, Lee Hye Won, Lai-Hung Wong Grace, Armandi Angelo, Shang Ying, Pennisi Grazia, Llop Elba, Yoneda Masato, de Saint-Loup Marc, Lara-Romero Carmen, Gallego-Durán Rocio, Asgharpour Amon, Kim-Jun Teh Kevin, Sau-Wai Chan Mandy, Lin Huapeng, Liu Wen-Yue, Song Sherlot Juan, Al-Hamoudi Waleed K, Isoda Hiroshi, Miyake Teruki, Satapathy Sanjaya K, Li Mengyi, Sharma Keshni, Emadeldeen Mohammed, Zhou Ling, Tong Xiaofei, Bazerbachi Fateh, Fan Xiaotang, Xiao Huanming, Ye Junzhao, Xu Liang, Wang Xiaolin, Wei Yi-Xuan, Zoncape Mirko, Li Wenhao, Wong Vincent Wai-Sun, Zheng Ming-Hua, VCTE-Prognosis Study Group, Paired Liver Biopsy Group

СтатьяПеревод в очереди

Аннотация

BACKGROUND & AIMS: Fibrosis-4 Index (FIB-4) is a noninvasive tool for assessing liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD). However, its role of dynamic FIB-4 for assessing fibrosis progression and predicting clinical outcomes remains unclear. The aim of this study was to examine the association between changes in FIB-4 and changes in liver stiffness, fibrosis progression, and outcomes in MASLD.

METHODS

Three cohorts were analyzed: VCTE-Prognosis cohort (n = 10,203) for stiffness progression, Paired Liver Biopsy cohort (n = 1,145) for fibrosis progression, and Wenzhou Real-World (WRW) cohort (n = 41,105) for clinical outcomes. Stiffness progression was defined as an increase in liver stiffness measurement, and fibrosis progression by a 1-stage increase. Outcomes included all-cause mortality, cardiovascular events, and liver-related events (LREs). FIB-4 was dichotomized into low (<1.3) and high (≥1.3). Increases were defined as ≥20% rise and to ≥1.3 in the low FIB-4 group, and ≥20% rise in the high FIB-4 group.

RESULTS

In the VCTE-Prognosis cohort, stiffness progression was more likely with increasing vs stable FIB-4 (adjusted odds ratio [OR], 2.36; P < .001) in those with low baseline FIB-4. In the high FIB-4 group, stiffness progression rates increased from stable to increasing FIB-4 (adjusted OR, 3.42; P < .001). In the Paired Liver Biopsy cohort, fibrosis progression was more frequent with increasing FIB-4 (adjusted OR, 2.20; P = .004 in low FIB-4; adjusted OR, 3.68; P < .001 in high FIB-4). In the WRW cohort, an increase in dynamic FIB-4 was linked to higher risks for all-cause mortality, cardiovascular events, and LREs (all P < .001).

CONCLUSIONS

Dynamic FIB-4 monitoring tracks fibrosis and stiffness progression and predicts clinical outcomes in MASLD.

Для цитирования: Zhou Xiao-Dong, Li Yu-Ting, Kim Seung Up, Yip Terry Cheuk-Fung, Petta Salvatore, Nakajima Atsushi, Tsochatzis Emmanuel, Shi Junping, Chan Wah-Kheong, Boursier Jérôme, Bugianesi Elisabetta, Yilmaz Yusuf, Hagström Hannes, Romero-Gomez Manuel, Alswat Khalid, Calleja José Luis, Takahashi Hirokazu, de Lédinghen Victor, Shalimar, Castéra Laurent, Sanyal Arun J, Goh George Boon-Bee, Newsome Philip N, Fan Jian-Gao, Lai Michelle, Aggarwal Sandeep, Kechagias Stergios, Hiasa Yoichi, Zhang Zhongtao, George Jacob, El-Kassas Mohamed, Chen Jinjun, You Hong, Abu Dayyeh Barham K, Sheng Huiping, Adams Leon A, Wang Jing, He Fangping, Liang Huiqing, Yang Yong-Feng, Chi Xiaoling, Zhong Bihui, Bi Yan, Mi Yuqiang, Zhu Yongfen, Bai Rixing, Zhang Jing, Wang Bingyuan, Song Jinghai, Deng Hong, Xie Qing, Bai Lang, Xin Yongning, Xie Wen, Li Jie, Fournier-Poizat Céline, Wu Chutian, Lee Hye Won, Lai-Hung Wong Grace, Armandi Angelo, Shang Ying, Pennisi Grazia, Llop Elba, Yoneda Masato, de Saint-Loup Marc, Lara-Romero Carmen, Gallego-Durán Rocio, Asgharpour Amon, Kim-Jun Teh Kevin, Sau-Wai Chan Mandy, Lin Huapeng, Liu Wen-Yue, Song Sherlot Juan, Al-Hamoudi Waleed K, Isoda Hiroshi, Miyake Teruki, Satapathy Sanjaya K, Li Mengyi, Sharma Keshni, Emadeldeen Mohammed, Zhou Ling, Tong Xiaofei, Bazerbachi Fateh, Fan Xiaotang, Xiao Huanming, Ye Junzhao, Xu Liang, Wang Xiaolin, Wei Yi-Xuan, Zoncape Mirko, Li Wenhao, Wong Vincent Wai-Sun, Zheng Ming-Hua, VCTE-Prognosis Study Group, Paired Liver Biopsy Group. Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2025. DOI: 10.1016/j.cgh.2025.07.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.